代表性成果 (論文/專利/專著等) |
1. AiyunLi, LiGuan, WanzhenSu, NingZhao, XuwenSong, JinWang, XiaoxiaoTang, WeizeLi&XiangyingJiao. TXNIP inhibition in the treatment of type 2 diabetes mellitus: design, synthesis, and biological evaluation of quinazoline derivatives. Journal of Enzyme Inhibition and Medicinal Chemistry, 2023, 38(1): 2166937. 2. Aiyun L, Yichao Z, Jin W, Yan Z, Wanzhen S, Feng G, Xiangying J. Txnip gene knockout ameliorated HFD-induced cardiomyopathy via regulating mitochondria dynamics and fatty acid oxidation. J Cardiovasc Pharmacol. 2023 Mar 8. PMID: 36888974 3. Zhandong Lei, Yunfei Chen, Jin Wang, Yan Zhang, Wenjuan Shi, Xuejiao Wang, Dehai Xing, Dongxue Li, Xiangying Jiao. Txnip deficiency promotes β-cell proliferation in the HFD-induced obesity mouse model. Endocr Connect, 2022, 11, e210641. 4. Jin Wang, Xue-Jiao Wang, Yan Zhang, Wen-Juan Shi1, Zhan-Dong Lei1, Xiang-Ying Jiao. TXNIP knockout improves cardiac function after myocardial infarction by promoting angiogenesis and reducing cardiomyocyte apoptosis. Cardiovasc Diagn Ther 2022;12(3):289-304. 5. Aiyun Li, Wenjuan Shi, Jin Wang, Xuejiao Wang, Yan Zhang, Zhandong Lei, Xiang-Ying Jiao. The gene knockout of angiotensin II type 1a receptor improves high-fat diet-induced obesity in rat via promoting adipose lipolysis. PLoS ONE 17(7): e0267331. |